15-89777028-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001039958.2(MESP2):c.671C>T(p.Ser224Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00441 in 1,593,132 control chromosomes in the GnomAD database, including 282 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001039958.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MESP2 | NM_001039958.2 | c.671C>T | p.Ser224Phe | missense_variant | 1/2 | ENST00000341735.5 | NP_001035047.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MESP2 | ENST00000341735.5 | c.671C>T | p.Ser224Phe | missense_variant | 1/2 | 1 | NM_001039958.2 | ENSP00000342392.3 | ||
MESP2 | ENST00000560219.2 | c.31-1037C>T | intron_variant | 1 | ENSP00000452998.1 | |||||
MESP2 | ENST00000558723.1 | n.39-1037C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0238 AC: 3627AN: 152186Hom.: 157 Cov.: 32
GnomAD3 exomes AF: 0.00524 AC: 1071AN: 204502Hom.: 37 AF XY: 0.00392 AC XY: 445AN XY: 113540
GnomAD4 exome AF: 0.00234 AC: 3374AN: 1440830Hom.: 122 Cov.: 34 AF XY: 0.00196 AC XY: 1401AN XY: 715540
GnomAD4 genome AF: 0.0240 AC: 3649AN: 152302Hom.: 160 Cov.: 32 AF XY: 0.0234 AC XY: 1739AN XY: 74470
ClinVar
Submissions by phenotype
Spondylocostal dysostosis 2, autosomal recessive Benign:3
Benign, criteria provided, single submitter | clinical testing | Counsyl | Jan 09, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 26, 2019 | - - |
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 10, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at